Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial

Autor: Zhao, Ze-Rui *, Liu, Shi-Liang *, Zhou, Ting *, Chen, Gang *, Long, Hao *, Su, Xiao-Dong, Zhang, Xu, Fu, Jian-Hua, Lin, Peng, Zhang, Lan-Jun, Rong, Tie-Hua, Wu, Jia-Di, Li, Zhi-Chao, Su, Hui-Lin, Chen, Ji-Yang, Yang, Yun-Peng, Lin, Yong-Bin, Xi, Mian, Yang, Hong *
Zdroj: In The Lancet Respiratory Medicine December 2024 12(12):988-996
Databáze: ScienceDirect